6 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
2021 ACR/VF Guidelines ... for Management ... Arteritis (GCA) #GiantCell ... #rheumatology # ... algorithm #vasculitis
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Algorithm - ACR ... /VF 2021 Guidelines ... → High-dose IV pulse ... @MithuRheum #GiantCell ... #algorithm #rheumatology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
) - Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... high-dose oral or pulse ... #algorithm #rheumatology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... Active Severe → Pulse ... #algorithm #rheumatology